Delcath Systems (DCTH) EPS (Weighted Average and Diluted) Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -19.74% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.20% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 88.89% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 47.37% |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn | -200.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200.00% |
| Dec 31, 2025 | 44.44% |
| Sep 30, 2025 | -66.67% |
| Jun 30, 2025 | 114.58% |
| Mar 31, 2025 | 106.67% |
| Dec 31, 2024 | 72.73% |
| Sep 30, 2024 | 105.26% |
| Jun 30, 2024 | 17.24% |
| Mar 31, 2024 | 41.56% |
| Dec 31, 2023 | 60.24% |
| Sep 30, 2023 | -18.75% |
| Jun 30, 2023 | 53.23% |
| Mar 31, 2023 | 30.00% |
| Dec 31, 2022 | -25.76% |
| Sep 30, 2022 | -2.13% |
| Jun 30, 2022 | -29.17% |
| Mar 31, 2022 | -5.77% |
| Dec 31, 2021 | -10.00% |
| Sep 30, 2021 | 18.97% |
| Jun 30, 2021 | 49.47% |
| Mar 31, 2021 | 99.04% |
| Dec 31, 2020 | 99.56% |
| Sep 30, 2020 | 98.43% |
| Jun 30, 2020 | 96.75% |
| Mar 31, 2020 | -43.88% |
| Sep 30, 2019 | -29,428.00% |
| Jun 30, 2019 | -705.79% |
| Mar 31, 2019 | -788.45% |
| Sep 30, 2018 | 99.99% |
| Jun 30, 2018 | 99.47% |
| Mar 31, 2018 | 100.02% |
| Jun 30, 2017 | -31,033.79% |
| Jun 30, 2016 | -1,370.00% |
| Dec 31, 2015 | 16.55% |
| Jun 30, 2015 | 42.31% |
| Dec 31, 2014 | 63.14% |
| Jun 30, 2014 | 42.86% |
| Dec 31, 2013 | 72.76% |
| Dec 31, 2012 | -973.97% |